SCHEMBL9938432

SCHEMBL9938432

NC(=O)CC1=NC=CCN1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.32
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28902470 0.63 TDP1 (0.33)
SCHEMBL4602159 0.63 HTT (0.32) HTTCA2
SCHEMBL4314716 0.62
SCHEMBL13134064 0.62
SCHEMBL4493627 0.62
SCHEMBL28987550 0.59 HTT (0.32) HTTCA2
SCHEMBL30149206 0.59 HTT (0.32) HTTCA2
SCHEMBL9698996 0.58 RECQL (0.40)
SCHEMBL9845818 0.57
SCHEMBL4765510 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651403-A2 USE OF LP-PLA2 INHIBITORS IN THE TREATMENT AND PREVENTION OF EYE DISEASES Glaxo Group Limited (GB) 2013-10-23 EP claimed
WO-2012080497-A2 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES GLAXO GROUP LIMITED (GB) 2012-06-21 WO claimed